Inventor · disambiguated record
John Amedio
Also filed as: AMEDIO JOHN · AMEDIO JOHN C · AMEDIO JR JOHN C
13 granted patents·12 pending applications·136 citations·filing 1995–2024
91Inventor score
Top patents by PatentIndex Score
25 records- 0194US6652835B1Targeting multimeric imaging agents through multilocus bindingEPIX MEDICAL INC·Filed 2000·Granted Nov 25, 2003·64 cites·15 claims
- 0292US10183951B2Solid forms of a thienopyrimidinedione ACC inhibitor and methods for production thereofGILEAD APOLLO LLC·Filed 2017·Granted Jan 22, 2019·14 cites·10 claims
- 0387US7238341B2Peptide-based multimeric targeted contrast agentsEPIX PHARM INC·Filed 2004·Granted Jul 3, 2007·18 cites·7 claims
- 0486US12012412B2Solid forms of pyrazolo[3,4-d]pyrimidine compoundsPFIZER·Filed 2022·Granted Jun 18, 2024·1 cites·19 claims
- 0577US5608061AProcess for preparing 1,4,8,11-tetraazacyclotetradecaneJOHNSON MATTHEY PLC·Filed 1995·Granted Mar 4, 1997·24 cites·20 claims
- 0676US8048906B2Optically pure and enriched isomers of chelating ligands and contrast agentsCATALYST MEDICAL·Filed 2006·Granted Nov 1, 2011·3 cites·33 claims
- 0776US7927581B2Peptide-based multimeric targeted contrast agentsFACTOR 1A LLC·Filed 2005·Granted Apr 19, 2011·1 cites·10 claims
- 0870US8664201B2Synthesis and formulations of salts of isophosphoramide mustard and analogs thereofWALIGORA FRANK WALTER·Filed 2009·Granted Mar 4, 2014·2 cites·18 claims
- 0967US2025145630A1Polymorphs of a pyridinylimidazo[1,2-b]pyridazineCARDURION PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1063US2024300961A1Solid forms of pyrazolo[3,4-d]pyrimidine compoundsPFIZER·Filed 2024·Application pending·0 cites
- 1161US9145431B2Synthesis and formulations of salts of isophosphoramide mustard and analogs thereofWALIGORA FRANK W·Filed 2014·Granted Sep 29, 2015·0 cites·15 claims
- 1261US2007185311A1Peptide-Based Multimeric Targeted Contrast AgentsEPIX PHARM INC·Filed 2006·Application pending·0 cites
- 1359US9254298B2Synthesis and formulations of salts of isophosphoramide mustard and analogs thereofZIOPHARM ONCOLOGY INC·Filed 2015·Granted Feb 9, 2016·0 cites·30 claims
- 1459US2016215005A1Synthesis and formulations of salts of isophosphoramide mustard and analogs thereofZIOPHARM ONCOLOGY INC·Filed 2016·Application pending·0 cites
- 1558US2024408042A1Orally disintegrating baclofen compositions and methods of making sameCLINICAL RES ASSOCIATES LLC·Filed 2023·Application pending·0 cites
- 1656US9340563B2Salts of isophosphoramide mustard and analogs thereofZIOPHARM ONCOLOGY INC·Filed 2013·Granted May 17, 2016·0 cites·8 claims
- 1756US5919967AProcess for synthesizing phosphodiestersEPIX MEDICAL INC·Filed 1997·Granted Jul 6, 1999·9 cites·17 claims
- 1856US2004005274A1Targeting multimeric imaging agents through multilocus bindingEPIX MEDICAL INC A DELAWARE CO·Filed 2003·Application pending·0 cites
- 1954US8604007B2Salts of isophosphoramide mustard and analogs thereofAMEDIO JR JOHN C·Filed 2008·Granted Dec 10, 2013·0 cites·29 claims
- 2054US2006155120A1Optically pure and enriched isomers of chelating ligands and contrast agentsAMEDIO JOHN C·Filed 2004·Application pending·0 cites
- 2150US2014004192A1Pharmaceutical formulations of indibulin and uses thereofZIOPHARM ONCOLOGY INC·Filed 2013·Application pending·0 cites
- 2247US2020069592A1Hsp90 inhibitor oral formulations and related methodsSAMUS THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2345US2016304546A1Compounds and methods for the treatment of cancerAMEDIO JOHN C JR·Filed 2014·Application pending·0 cites
- 2441US2010331403A1Compounds and methods for the treatment of cancerAMEDIO JR JOHN C·Filed 2008·Application pending·0 cites
- 2529US2012219597A1Pharmaceutical formulations for indibulinAMEDIO JR JOHN C·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →